Sort
21,453 grants matching “tuberculosis”
METABOLIC REPROGRAMMING OF T CELL ENERGY METABOLISM IN TUBERCULOSIS AND HIV
$719,829Adrie Jc Steyn · University Of Alabama At Birmingham · R33 · FY2020 · AI
Natural Resistance to Mycobacterium Tuberculosis Infection
$719,693W. Henry Henry Boom · Case Western Reserve University · U01 · FY2015 · AI
Regulation of Expression and Mechanism of Action of Granulysin and RANTES
$719,644Alan Krensky · Basic Sciences · Z01 · FY2007 · CA
Epidemiology of Mycobacterial Infections
$719,634Deborah Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infection
$719,615Ryan C Bailey · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Non-canonical epitope presentation and antigen processing by MHC-E
$719,468Klaus J Frueh · Oregon Health & Science University · R01 · FY2023 · AI
Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda
$719,424John Lucian Davis · University Of California, San Francisco · R01 · FY2013 · AI
HIV-induced Defects in Pulmonary Macrophages Exacerbate Mycobacterium Tuberculosis Co-infection
$719,391Janice J Endsley · University Of Texas Med Br Galveston · R01 · FY2016 · HL
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$719,048Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2025 · AI
Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance
$718,961Eric L Nuermberger · Johns Hopkins University · R01 · FY2018 · AI
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR
$718,939Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2025 · AI
Spatio-temporal data integration methods for infectious disease surveillance
$718,887Justin V Remais · University Of California Berkeley · R01 · FY2018 · AI
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages
$718,869Nevan J Krogan · University Of California, San Francisco · R01 · FY2019 · AI
Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection
$718,758Riti Sharan · Texas Biomedical Research Institute · R56 · FY2024 · AI
Innate immune response of LTBI+HIV+ children
$718,640Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2020 · AI
Who are the Ultra-positive, culture-negative? Understanding the trajectories of individuals in Uganda with trace M. tuberculosis nucleic acid in sputum
$718,579Emily A Kendall · Johns Hopkins University · R01 · FY2024 · HL
Bacterial and Molecular Determinants of Mycobacterial Impermeability
$718,478Marcos M. Pires · University Of Virginia · R01 · FY2025 · AI
Epidemiology of Mycobacterial Infections
$718,390Deborah Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Rapid Diagnosis of XDR Tuberculosis
$718,373David Alland · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · AI
Lethal action of fluoroquinolones with non-growing Mycobacterium tuberculosis
$718,233Karl A Drlica · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · AI
NEVADA - TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM
$718,073Richard Whitely · Health And Human Services, Nevada Department Of · U52 · FY2015 · PS
Chemical genetics of M. tuberculosis DosRST signaling and persistence
$717,958Robert B Abramovitch · Michigan State University · R01 · FY2020 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM FUNDING
$717,808Molly Harrar · Philadelphia Departmentof Public Health · U52 · FY2014 · PS
Biocontainment Research support services core
$717,476Farhang Alem · George Mason University · UC7 · FY2023 · AI
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV
$717,387James C M Brust · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI